ARTICLE | Clinical News
Palmaz-Schatz: IsoStent will start a Phase I trial in the next month in 30 patients.
August 19, 1996 7:00 AM UTC
IsoStent Inc., San Carlos, Calif. Product: Palmaz-Schatz stent made radioactive Indication: Prevent restenosis after coronary artery treatment Status: IsoStent will start a Phase I trial in the next ...